A review of the biological and potential therapeutic actions of Harpagophytum procumbens

Phytotherapy Research

Volumn 21, Issue 3, 2007, Pages 199-209

  Grant, L ^a   McBean, D E ^b   Fyfe, L ^b   Warnock, A Mary ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Antiinflammatory; Devil's claw; Harpagophytum procumbens

Indexed keywords

FLEXILOGES; HARPAGOPHYTUM EXTRACT; HARPAGOPHYTUM PROCUMBENS EXTRACT; UNCLASSIFIED DRUG;

BACKACHE; BIOLOGICAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ACTIVITY; DRUG ISOLATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEVER; GASTROINTESTINAL DISEASE; HARPAGOPHYTUM; HEADACHE; HIP OSTEOARTHRITIS; HUMAN; INFLAMMATION; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL PAIN; NONHUMAN; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HARPAGOPHYTUM; HUMANS; INFLAMMATION; PAIN; PHYTOTHERAPY; PLANT EXTRACTS;

ANIMALIA; HARPAGOPHYTUM PROCUMBENS;

EID: 33947573369     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2029     Document Type: Review

References (73)

1. Andersen OML, Santos EH, Seabra LB, da Silva AA, Tufik S. 2004. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol 91: 325-330.
2. Arrigoni-Martelli E. 1977. Inflammation and Antiinflammatories. Spectrum Publications: New York.
3. Baghdikian B, Lanhers MC, Fleurentin J et al. 1997. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med 63: 171-176.
4. Belaiche P. 1982. Étude clinique de 630 cas d'arthrose traités par le nébulisat aqueux d'Harpagophytum procumbens (Radix). Phytotherapy 1: 22-28.
5. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. 1999. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 117: 1234-1237.
6. Bermejo BP, Díaz LAM, Silván SAM et al. 2000. Effects of some iridoids from plant origin on arachidonic acid metabolism in cellular systems. Planta Med 66: 324-328.
7. Betancor-Fernández A, Pérez-Gálvez A, Sies H, Stahl W. 2003. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 55: 981-986.
8. Bhattacharya A, Bhattacharya SK. 1998. Anti-oxidant activity of Harpagophytum procumbens (Devil's claw). Br J Phytother 5: 68-71.
9. Boje K, Lechtenberg M, Nahrstedt A. 2003. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 69: 820-825.
10. Burger JFW, Brandt EV, Ferreira D. 1987. Iridoid and phenolic glycosides from Harpagophytum procumbens. Phytochemistry 26: 1453-1457.
11. Chan TY. 2001. Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 35: 501-504.
12. Chantre P, Cappelaere A, Leblan D, Geudon D, Vandermander J, Fournie B. 2000. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 7: 177-183.
13. Chrubasik S, Junck H, Breitschwerdt H, Conradt C, Zappe H. 1999. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomised, placebo-controlled, double-blind study. Eur J Anaesthiol 16: 118-129.
14. Chrubasik S, Kunzel O, Thanner J, Conradt C, Black A. 2005. A 1-year follow-up after a pilot study with Doloteffin for low back pain. Phytomedicine 12: 1-9.
15. Chrubasik JE, Lindhorst E, Neumann E et al. 2006. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine 13: 598-600.
16. Chrubasik S, Model A, Black A, Pollack S. 2003. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology 42: 141-148.
17. Chrubasik S, Schmidt A, Junck H, Pfisterer M. 1997. Wirksamkeit und Wirkschaftlichkeit von Teulfelskrallenwurzelextrakt bie runkenschmerzen: Erst ergbnisse einer therapeutischen. Kohortenstudie Forsch Komplementarmed 332-336.
18. Chrubasik S, Sporer F, Dillmann-Marschner R, Friedmann A, Wink M. 1999/2000. Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets. Phytomedicine 6: 469-473.
19. Chrubasik S, Thanner J, Kunzel O, Conradt C, Black A, Pollak S. 2002. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin in patients with pain in the lower back, knee or hip. Phytomedicine 9: 181-194.
20. Chrubasik S, Zimpfer CH, Schutt U, Ziegler R. 1996. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 3: 1-10.
21. Eichler O, Koch C. 1970. Uber die antiphlogistische, analgetishche, and spasmolytische Wirksamkeit von Harpagophytum procumbens. Arzeimettelforsch Drug Res 20: 107-109.
22. Erdos A, Fontaine R, Friehe H, Durand R, Poppinghaus T. 1978. Contribution to the pharmacology of different extracts as well as the harpagoside from Harpagophytum procumbens DC. Planta Med 34: 97-108.
23. Ernst E. 2000. Herbal medicines: where is the evidence? Br Med J 321: 395-396.
24. ESCOP Scientific Committee. 2003. ESCOP Monographs. Harpagophyti radix. Thieme Press: Stuttgart, New York.
25. Fiebich BL, Heinrich M, Hiller K-O, Kammerer N. 2001. Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 8: 28-30.
26. Fleurentin J, Mortier F. 1997. Entzuendungshemmende und analgetische Wirkungen von Harpagophytum procumbens and H. Zeyheri. In Rheumatatherapie mit Phytopharmaka, Chrubasik S, Wink M (eds). Hippocrates: Stuttgart, 68-76.
27. Frerick H, Biller A, Schmidt U. 2001. Stufenschema bei coxarthrose. Der Kassenarzt 5: 34-41.
28. Gagnier JJ, Chrubasik S, Manheimer E. 2004. Harpagophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med 4: 13.
29. Gobel H, Heinze A, Ingwersen M, Neiderberger U, Gerber D. 2001. Effects of Harpagophytum procumbens LI 174 (devil's claw) on sensory, motor and vascular muscle reagibility in the treatment of unspecific back pain. Schmerz 15: 10-18.
30. Goldring SR, Goldring MB. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 427: S27-S36.
31. Gordon DW, Rosenthal G, Hart J, Sirotta R, Baker AL. 1995. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 273: 489-490.
32. Gorski JC, Huang S-M, Pinto A et al. 2004. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 75: 89-100.
33. Grahame R, Robinson BV. 1981. Devils's claw (Harpagophytum procumbens): pharmacological and clinical studies. Ann Rheum Dis 40: 632.
34. 2-extracts. J Pharm Biomed Anal 37: 817-821.
35. Guyader M. 1984. Les Plantes Antirheumatismales. Études Historique et Pharmacologique, et Etude Clinique du Nébulisat d'Harpagophytum procumbens DC chez 50 Patients Arthrosiquws Suivis in Service Hospitalier [dissertation]. Université Pierre et Marie Curie, Paris.
36. Haag-Berrurier M, Kuballa B, Anton R. 1978. Dosage des glucoiridoides totaux dans la racine d'Harpagopytum procumbens DC und Harpagophytum zeheri DECNE. Planta Med 12: 197-206.
37. Halliwell B, Hoult JR, Blake DR. 1988. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J 2: 2867-2873.
38. Harvey J, Colin-Jones DG. 1981. Mistletoe hepatitis. Br Med J 282: 186-187.
39. Huang TH, Tran VH, Duke RK et al. 2005. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation. J Ethnopharmacol 104: 149-155.
40. Jadot G, Lecomte A. 1992. Activite anti-inflammatoire d'Harpagophytum procumbens DC. Lyon Med Med Med Sud-Est 28: 833-835.
41. Jang MH, Lim S, Han SM et al. 2003. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 93: 367-371.
42. Jaswal S, Mehta HC, Sood AK, Kaur J. 2003. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338: 123-129.
43. Kaszkin M, Beck KF, Koch E et al. 2004. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 11: 585-595.
44. Kemper KJ. 1999. Devils Claw (Harpagophytum procumbens). Longwood Herbal Task Force. http://www.longwoodherbal .org/devilsclaw/devilsclaw.pdf
45. Kundu JK, Mossanda KS, Na H, Surh Y. 2005. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett 218: 21-31.
46. Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. 2002. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther 16: 197-205.
47. Lanhers MC, Fleurentin J, Mortier F, Vinche A, Younos C. 1992. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 58: 117-123.
48. Laudahn D, Walper A. 2001. Efficacy and tolerance of Harpagophytum extract LI174 in patients with chronic non-radicular back pain. Phytother Res 15: 621-624.
49. Lecomte A, Costa JP. 1992. Harpagophytum dans l'arthrose: Etudes en double insu contre placebo. 37°2 Le Magazine 15: 27-30.
50. Loew D, Mollerfeld J, Schrodter A, Puttkammer S, Kaszkin M. 2001. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 69: 356-364.
51. Mahomed IM, Ojewole JAO. 2004. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother Res 18: 982-989.
52. Mahomed IM, Ojewole JAO. 2006. Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceael secondary root aqueous extract in mice. Brain Res Bull 69: 57-62.
53. Manez S, Alcaraz MJ, Payá M, Rios JL, Hancke JL. 1990. Selected extracts from medicinal plants as anti-inflammatory agents. Planta Med 56: 656.
54. McLeod DW, Revell P, Robinson BV. 1979. Investigations of Harpagophytum procumbens (Devil's Claw) in the treatment of experimental inflammation and arthritis in the rat. Br J Pharmacol 66: 140-141.
55. Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Harcourt Publishers Ltd: London.
56. Miskelly FG, Goodyer LI. 1992. Hepatic and pulmonary complications of herbal medicine. Postgrad Med 68: 935-936.
57. Moussard C, Alber D, Toubin MM, Thevenon N, Henry JC. 1992. A drug used in traditional medicine, Harpagophytum procumbens: no evidence for NSAID-like effect on whole blood eicosanoid production in human. Prostaglandins Leukot Essent Fatty Acids 46: 283-286.
58. Mukherjee D, Nissen SE, Topol EJ. 2001. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954-959.
59. Page CP, Curtis MJ, Sutter MC, Walker MJA, Hoffman BB. 1997. Integrated Pharmacology. Mosby: London.
60. Pinget M, Lecomte A. 1997. Die Wirkung der 'Harpagophytum Arkocaps' bei degenerativem Rheuma. Naturheilpraxis 50: 267-269.
61. Rang HP, Dale MM, Ritter JM, Moore PK. 2003. Pharmacology, 5th edn. Churchill Livingstone: Edinburgh.
62. Schruffler H. 1980. Salus Teufelskralle-Tabletten. Ein fortschritt in der nicht steroidalen antirheumatischen therapie. Die Medizinische Publikation: 1-8.
63. Schulze-Tanzil G, Hansen C, Shakibaei M. 2004. Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittelforschung 45: 213-220.
64. Soulimani R, Younos C. 1994. The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example extracts of Harpagophytum procumbens. Can J Physiol Pharmacol 72: 1532-1536.
65. Tippler B, Syrovets T, Plaza N, Loew D, Simmet T. 1997. Harpagophytum procumbens DC used in traditional medicine inhibits eicosanoid biosynthesis in human whole blood. Int J Tiss React 19: 101-102.
66. Tyler VE. 1993. The Honest Herbal. Pharmaceutical Products Press: New York.
67. Unger M, Frank A. 2004. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom 18: 2273-2281.
68. Velpandian T, Jasuja R, Bhardwaj RK, Jaiswal J, Gupta SK. 2001. Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet 26: 241-247.
69. Wegener T. 2000. Devil's Claw: from African traditional remedy to modern analgesic and antiinflammatory. Herbal Gram 50: 47-54.
70. Wegener T, Lupke NP. 2003. Treatment of patients with arthrosis of hip or knee with an aqueous extract of Devil's Claw (Harpagophytum procumbens, DC). Phytother Res 17: 1165-1172.
71. Whitehouse LW, Znamirowska M, Paul CJ. 1983. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J 129: 249-251.
72. Whiting PW, Clouston A, Kerlin P. 2002. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 177: 440-443.
73. Zorn B. 1958. Uber die antiarthritische Wirkung der Harpagophytum Wurtzel: vorlaufige Mittleilung. Z Rheumatol 17: 134-138.